294 related articles for article (PubMed ID: 28866306)
1. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.
Kim HS; Kim JH; Seo YM; Chun YH; Yoon JS; Kim HH; Lee JS; Kim JT
Ann Allergy Asthma Immunol; 2017 Nov; 119(5):441-445. PubMed ID: 28866306
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
Kim CK; Callaway Z; Fletcher R; Koh YY
J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
[TBL] [Abstract][Full Text] [Related]
3. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein.
Taniuchi S; Chihara J; Kojima T; Yamamoto A; Sasai M; Kobayashi Y
J Dermatol Sci; 2001 May; 26(1):79-82. PubMed ID: 11323224
[TBL] [Abstract][Full Text] [Related]
4. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.
Pucci N; Lombardi E; Novembre E; Farina S; Bernardini R; Rossi E; Favilli T; Vierucci A
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858
[TBL] [Abstract][Full Text] [Related]
5. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis.
Wu KG; Li TH; Chen CJ; Cheng HI; Wang TY
Int J Immunopathol Pharmacol; 2011; 24(1):15-23. PubMed ID: 21496383
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
Kim KW; Lee KE; Kim ES; Song TW; Sohn MH; Kim KE
Lung; 2007; 185(2):97-103. PubMed ID: 17393238
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.
Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
Sci Rep; 2017 Jul; 7(1):4833. PubMed ID: 28684769
[TBL] [Abstract][Full Text] [Related]
8. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction.
Ott NL; Gleich GJ; Peterson EA; Fujisawa T; Sur S; Leiferman KM
J Allergy Clin Immunol; 1994 Jul; 94(1):120-8. PubMed ID: 8027490
[TBL] [Abstract][Full Text] [Related]
9. Serum eosinophil cationic protein in children with atopic dermatitis.
Murat-Susić S; Lipozencić J; Zizić V; Husar K; Marinović B
Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428
[TBL] [Abstract][Full Text] [Related]
10. Childhood atopic dermatitis-Brain-derived neurotrophic factor correlates with serum eosinophil cationic protein and disease severity.
Fölster-Holst R; Papakonstantinou E; Rüdrich U; Buchner M; Pite H; Gehring M; Kapp A; Weidinger S; Raap U
Allergy; 2016 Jul; 71(7):1062-5. PubMed ID: 27087278
[TBL] [Abstract][Full Text] [Related]
11. Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
Pham TH; Damera G; Newbold P; Ranade K
Respir Med; 2016 Feb; 111():21-9. PubMed ID: 26775606
[TBL] [Abstract][Full Text] [Related]
12. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
Gon Y; Ito R; Hattori T; Hiranuma H; Kumasawa F; Kozu Y; Endo D; Koyama D; Shintani Y; Eriko T; Soda K; Maruoka S; Hashimoto S
Allergy Asthma Proc; 2015; 36(6):e113-20. PubMed ID: 26534742
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables.
Park JH; Choi YL; Namkung JH; Kim WS; Lee JH; Park HJ; Lee ES; Yang JM
Br J Dermatol; 2006 Oct; 155(4):778-83. PubMed ID: 16965428
[TBL] [Abstract][Full Text] [Related]
14. Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity.
Goto T; Morioka J; Inamura H; Yano M; Kodaira K; Igarashi Y; Abe S; Kurosawa M
Allergol Int; 2007 Dec; 56(4):433-8. PubMed ID: 17965582
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis.
Tischendorf FW; Brattig NW; Burchard GD; Kubica T; Kreuzpaintner G; Lintzel M
Acta Trop; 1999 Mar; 72(2):157-73. PubMed ID: 10206116
[TBL] [Abstract][Full Text] [Related]
16. Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults.
Granger V; Zerimech F; Arab J; Siroux V; de Nadai P; Tsicopoulos A; Matran R; Akiki Z; Nadif R
Thorax; 2022 Jun; 77(6):552-562. PubMed ID: 34615736
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
[TBL] [Abstract][Full Text] [Related]
18. [Is the seric eosinophil cationic protein level a valuable tool of diagnosis in clinical practice?].
Moneret-Vautrin DA
Rev Med Interne; 2006 Sep; 27(9):679-83. PubMed ID: 16647168
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytes.
Amber KT; Chernyavsky A; Agnoletti AF; Cozzani E; Grando SA
Exp Dermatol; 2018 Dec; 27(12):1322-1327. PubMed ID: 30218612
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
Tsuda S; Kato K; Miyasato M; Sasai Y
J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
